- Home
- PMEC vs DTIL Comparison
PMEC vs DTIL Comparison
Compare PMEC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMEC | DTIL |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 123.0M |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PMEC | DTIL |
|---|---|---|
| Price | $1.08 | $5.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $47.00 |
| AVG Volume (30 Days) | 193.2K | ★ 256.9K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,349,000.00 | $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.54 | $3.61 |
| 52 Week High | $2.44 | $8.82 |
Technical Indicators
Market Signals| Indicator | PMEC | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 40.77 |
| Support Level | $0.97 | $4.70 |
| Resistance Level | $1.10 | $5.54 |
| Average True Range (ATR) | 0.09 | 0.40 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 58.54 | 28.71 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.